459 filings
S-3/A
PLSE
Pulse Biosciences Inc
Shelf registration (amended)
25 Apr 24
4:58pm
DEFA14A
PLSE
Pulse Biosciences Inc
23 Apr 24
Additional proxy soliciting materials
5:02pm
DEF 14A
PLSE
Pulse Biosciences Inc
Definitive proxy
23 Apr 24
4:59pm
S-3/A
PLSE
Pulse Biosciences Inc
Shelf registration (amended)
23 Apr 24
4:39pm
S-3/A
PLSE
Pulse Biosciences Inc
Shelf registration (amended)
15 Apr 24
9:56am
EFFECT
3g93 f73qle
9 Apr 24
Notice of effectiveness
12:15am
8-K
6nfhwc 0jyn6czpqjhk
28 Mar 24
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
4:18pm
8-K
nbd47w9 gqt
11 Mar 24
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
9:10am
8-K
wawm83waffdy3
14 Feb 24
Other Events
9:22am
8-K
uitbw
9 Jan 24
Regulation FD Disclosure
9:20am
8-K
7rl1gizif
2 Jan 24
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
9:20am
8-K
2ssoae k4pc3bxo
22 Dec 23
Submission of Matters to a Vote of Security Holders
9:08am
8-K
i00tym sh
20 Dec 23
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
9:06am
SC 13D/A
54uur4dttyub65zbpg
15 Dec 23
Pulse Biosciences / DUGGAN ROBERT W ownership change
12:00am
4
6da7gmev2jsrhyjox
14 Dec 23
Pulse Biosciences / ROBERT W DUGGAN ownership change
7:37pm
4
879 czumn8fh8kgexlu
13 Dec 23
Pulse Biosciences / ROBERT W DUGGAN ownership change
6:03pm
4
e469thquu
12 Dec 23
Pulse Biosciences / ROBERT W DUGGAN ownership change
7:28pm